Published in J Am Med Inform Assoc on August 28, 2009
Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS (2012) 2.65
Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology (2010) 2.64
Risk of cardiovascular events associated with current exposure to HIV antiretroviral therapies in a US veteran population. Clin Infect Dis (2015) 2.09
Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans. JAMA (2014) 1.95
Dispelling myths about rare disease registry system development. Source Code Biol Med (2013) 1.68
Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons. AIDS (2011) 1.57
HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV. Hepatology (2014) 1.46
Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study. Ann Intern Med (2011) 1.17
Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection. Hepatology (2016) 1.17
Surveillance for hepatocellular carcinoma: development and validation of an algorithm to classify tests in administrative and laboratory data. Dig Dis Sci (2010) 1.16
Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients. Clin Gastroenterol Hepatol (2011) 1.14
Rural residence is associated with delayed care entry and increased mortality among veterans with human immunodeficiency virus infection. Med Care (2010) 1.10
Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma. Clin Gastroenterol Hepatol (2011) 0.99
Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology (2013) 0.98
Statin Utilization and Recommendations Among HIV- and HCV-infected Veterans: A Cohort Study. Clin Infect Dis (2016) 0.98
Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors. Hepatology (2013) 0.96
Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis. Gastroenterology (2015) 0.92
Trends in biomedical informatics: most cited topics from recent years. J Am Med Inform Assoc (2011) 0.91
Cumulative HIV viremia and non-AIDS-defining malignancies among a sample of HIV-infected male veterans. J Acquir Immune Defic Syndr (2014) 0.90
A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans. AIDS (2014) 0.89
Serum albumin and short-term risk for mortality and cardiovascular disease among HIV-infected veterans. AIDS (2013) 0.89
Longer duration of combination antiretroviral therapy reduces the risk of Hodgkin lymphoma: A cohort study of HIV-infected male veterans. Cancer Epidemiol (2014) 0.88
Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology (2014) 0.87
Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection. Clin Infect Dis (2015) 0.85
The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection. J Acquir Immune Defic Syndr (2015) 0.83
Rural residence and adoption of a novel HIV therapy in a national, equal-access healthcare system. AIDS Behav (2013) 0.81
Race and other risk factors for incident proteinuria in a national cohort of HIV-infected veterans. J Acquir Immune Defic Syndr (2014) 0.81
Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients. AIDS Behav (2013) 0.80
Association between Time on Protease Inhibitors and the Incidence of Squamous Cell Carcinoma of the Anus among U.S. Male Veterans. PLoS One (2015) 0.80
Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphoma. PLoS One (2013) 0.80
Hepatocellular carcinoma screening practices in the Department of Veterans Affairs: findings from a national facility survey. Dig Dis Sci (2013) 0.77
Racial Disparities in Creatinine-based Kidney Function Estimates Among HIV-infected Adults. Ethn Dis (2016) 0.76
Tenofovir exposure alters associations of serum bicarbonate with chronic kidney disease risk in HIV-infected veterans. AIDS (2016) 0.75
Patterns of Healthcare Utilization Among Veterans Infected With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) and Coinfected With HIV/HCV: Unique Burdens of Disease. Open Forum Infect Dis (2016) 0.75
Statin drugs decrease progression to cirrhosis in HIV/HCV co-infected individuals. AIDS (2016) 0.75
Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA. Dig Dis Sci (2015) 0.75
Rapid Development of Specialty Population Registries and Quality Measures from Electronic Health Record Data*. An Agile Framework. Methods Inf Med (2017) 0.75
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med (2002) 36.55
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet (2001) 35.17
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med (2006) 18.63
Use of electronic health records in U.S. hospitals. N Engl J Med (2009) 14.36
Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods. JAMA (1999) 5.73
Building a comprehensive clinical information system from components. The approach at Intermountain Health Care. Methods Inf Med (2003) 4.02
A comparison of the completeness and timeliness of automated electronic laboratory reporting and spontaneous reporting of notifiable conditions. Am J Public Health (2008) 3.81
VistA--U.S. Department of Veterans Affairs national-scale HIS. Int J Med Inform (2003) 3.45
Predictors of response of US veterans to treatment for the hepatitis C virus. Hepatology (2007) 2.89
Electronic Support for Public Health: validated case finding and reporting for notifiable diseases using electronic medical data. J Am Med Inform Assoc (2008) 2.44
The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients. Ann Rheum Dis (2001) 1.70
Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin Infect Dis (2007) 1.62
The Immunology Case Registry. J Clin Epidemiol (2001) 1.56
Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2005) 1.28
Electronic patient registries improve diabetes care and clinical outcomes in rural community health centers. J Rural Health (2009) 1.14
Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virus. J Viral Hepat (2006) 1.00
Postmarketing use of enfuvirtide in veterans: provider compliance with criteria for use, overall efficacy, and tolerability. Ann Pharmacother (2008) 0.89
Provider prescribing of 4 antiretroviral agents after implementation of drug use guidelines in the Department of Veterans Affairs. J Manag Care Pharm (2009) 0.87
Some principles of the development of a clinical database/national register of selected inflammatory rheumatic diseases in the Czech Republic. Int J Med Inform (2005) 0.85
Retention in care: a challenge to survival with HIV infection. Clin Infect Dis (2007) 10.66
Development and verification of a "virtual" cohort using the National VA Health Information System. Med Care (2006) 4.28
A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C. Clin Gastroenterol Hepatol (2011) 3.11
Predictors of response of US veterans to treatment for the hepatitis C virus. Hepatology (2007) 2.89
Human factors barriers to the effective use of ten HIV clinical reminders. J Am Med Inform Assoc (2003) 2.42
Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2005) 1.28
National quality forum performance measures for HIV/AIDS care: the Department of Veterans Affairs' experience. Arch Intern Med (2010) 1.24
An HIV collaborative in the VHA: do advanced HIT and one-day sessions change the collaborative experience? Jt Comm J Qual Patient Saf (2006) 1.11
Hepatitis C virus screening and prevalence among US veterans in Department of Veterans Affairs care. JAMA Intern Med (2013) 1.10
Comparative Metagenomics of Eight Geographically Remote Terrestrial Hot Springs. Microb Ecol (2015) 0.93
Impact of race/ethnicity and gender on HCV screening and prevalence among U.S. veterans in Department of Veterans Affairs Care. Am J Public Health (2014) 0.92
Postmarketing use of enfuvirtide in veterans: provider compliance with criteria for use, overall efficacy, and tolerability. Ann Pharmacother (2008) 0.89
Early virologic responses and hematologic safety of direct-acting antiviral therapies in veterans with chronic hepatitis C. Clin Gastroenterol Hepatol (2013) 0.84
A population approach to disease management: hepatitis C direct-acting antiviral use in a large health care system. J Manag Care Spec Pharm (2014) 0.83
Streamlining importation of outside prior DICOM studies into an imaging system. J Digit Imaging (2012) 0.82
Rural residence and adoption of a novel HIV therapy in a national, equal-access healthcare system. AIDS Behav (2013) 0.81
Total ankle arthroplasty in end-stage ankle arthritis. Curr Rev Musculoskelet Med (2013) 0.78
The vertical humeral osteotomy for stem removal in revision shoulder arthroplasty: results and technique. J Shoulder Elbow Surg (2011) 0.78
Screening for and prevalence of hepatitis B virus infection among high-risk veterans under the care of the U.S. Department of Veterans Affairs: a case report. Ann Intern Med (2014) 0.77
Effectiveness research in the evolving HCV landscape. Dig Dis Sci (2014) 0.75
Impact of sustained virologic response on all-cause mortality. Hepatology (2013) 0.75
Impact of provider type on hepatitis C outcomes with boceprevir-based and telaprevir-based regimens. J Clin Gastroenterol (2015) 0.75